Effect of local cannabinoid administration on knee osteoarthritis

Effect of local cannabinoid administration on knee osteoarthritis: A randomized triple-blind placebo based clinical trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20221218056851N2

Enrollment

Registered

2023-12-03

Start date

2023-10-23

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis. Osteoarthritis of knee

Interventions

Intervention 1: Intervention group: Canvert cream is produced according to the order of Alasht Pharmed Company in Mon Rogin Company in Iran, Alborz Province and contains cannabidiol. How to use the cr

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients over 18 years of age referred to the orthopedic clinic of Valiasr Arak Hospital with complaints of knee osteoarthritis pain.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: immediately and 12 weeks after. Method of measurement: WOMAC (Western ontario and mcmaster universities index) questionnaire.;Joint stiffness. Timepoint: immediately and 12 weeks after. Method of measurement: WOMAC questionnaire.;Limitation of movement. Timepoint: immediately and 12 weeks after. Method of measurement: WOMAC questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mona Hamedi Tabar

Arak University of Medical Sciences

hamedimona.1996@gmail.com+98 86 3417 3639

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026